Briefing Chat: 'External lungs' keep man alive for 48 hours until transplant

Sid att vi börvi jobbar med assets inom ekonomi och lön har vi fått ökad kontroll och jag känner mig in. Säker på att vi gör rätt. Det gör att jag tryggt kan fokusera på affärsverksamheten istället assets. Redovisning, revision och lön för dig som tänker nytt. Frisör, massör eller larmor. Servitör, ingenjör eller webbredaktör. Få hjälp med. Contacta os poichinhos. Tillsammans skapar vi ett hem till ditt företag.

Hi listeners, Benjamin here. Welcome to the Nature Briefing Podcast, the Friday show where we talk about a couple of stories we've read in the Nature Briefing, which is of course Nature's daily email about the latest science. And we're recording this in Nature Towers once again, so you might hear the hum of folk working in the background.

But we've got an exciting debut today. We've got a new member of the team, Maren Huntsberger. Maren, how are you doing? Hello, I'm very excited to be on the pod. Thanks for having me, Ben. I am nature's new senior multimedia producer. And I'm excited to be on the briefing today. Well very excited to have you here. And we've got a couple of stories

to talk about. But say, given that it's your first show, why don't you go first? Oh thank you. I'm absolutely buzzing. A paper just came out in Cell that has the most amazing top line of the story. Man survives forty-eight hours without his lungs. How? Right, please tell me. The answer is amazing technology. This is a new technology called a extracorporeal, total artificial lung system, of course.

T A L for short. Good. Nice and catchy. Yeah. And what happened is this patient came into the hospital because he had the flu and this put him into what's called acute respiratory distress syndrome. Essentially his lungs were filling with fluid and he couldn't breathe. So what do you do then? You put the patient on a ventilator. You know, many patients during COVID were put on ventilators because of this issue.

Unfortunately, ventilators do come with some problems, including the potential of introducing a bacterial infection. Now you and I are both former microbiologists, Ben. You've heard of Pseudomonas arigenosa. the foe of medics and doctors worldwide. It is really tricky to get off of a medical device and it is often antibacterial resistant. So it's very difficult to treat. So this poor guy, his lungs were totally failing and turning his entire body

septic. So his blood pressure's tanking, his organs are failing. What do you do? You take the lungs out. And this is clearly a medical emergency then and this is a drastic step. Absolutely. And it is something that does happen occasionally. So this is what's called a bridge technology to take someone from the point where their lungs have failed.

and get them to the point where they can get new lungs, where they can receive a lung transplant. So there is technology that has existed to do this, but it's Pretty finicky and it has some problems. It's really difficult as some of the researchers who have commented on this project to I don't know keep the heart beating without the lungs, right? Yeah, they kinda go together, right? Sounds tricky.

So the technology that already exists to do this is called ECMO, and it's been around since the 60s and 70s. It's used to keep a patient's heart and lungs alive and doing stuff while they're really struggling. But it's usually not used when the patient's lungs aren't in their body at all. So this is what this artificial lung system is able to do. It's able to keep the blood flow consistent and automatically modulate the pressure across the heart

without the lungs in the body. Wow. Okay. And well let's let's find out how did this person do then when they were hooked up to this system? Well one of the most interesting things about this story, at least to me, is that when they took the lungs out of his body, he immediately started to recover. So his sepsis goes away, his blood pressure re regulates, his organs start to come out of failure.

And it's all thanks to his heart still being able to pump and his blood still being able to be oxygenated by this artificial lung system. So that blood is being taken out of the heart and put into an external oxygenator and then pumped back into the heart on the other side so that it can then go to the rest of his tissues in his body. And so they take the lungs out, over forty eight hours he starts to recover, he becomes well enough to receive his lung transplant

And now, almost three years after the fact the paper just came out, but this did happen in twenty twenty three. Now almost three years later, he's doing really well, his doctors say he's healthy and his lungs are functioning normally. Well that's really good to hear. It is clearly a very, very extreme example of something that needs to be done to keep the patient alive. This is n equals one, is this?

Something that researchers are looking to make more widespread, do we think? Definitely. These researchers have made the technology and how it works. Everything about it open access, non proprietary for anyone around the world who is able to use it because patients do

often die waiting for lung transplant because their lungs fail before they're well enough to receive a transplant or before a transplant is ready. So the researchers are hoping that this artificial lung system will be able to bridge more and more patients to be able to get them to the point where they can receive a transplant. And and you're right, it is that weight that can really lead to very poor outcomes, even death. for people waiting for for transplants. And I can't help but think like

kidney dialysis or even iron lungs as well as as a way of mechanically keeping people alive or in a state that they can start recovering. And this is another one of those maybe. Definitely and definitely the most advanced version that we've seen so far and

one that does the best job of keeping the heart beating as it should with the proper pressure and the proper flow of blood between the chambers of the heart in order to make sure that, you know, this incredibly complex and risky goal of keeping someone alive without their lungs in their body

has the best chance of success. So this is definitely the most advanced version of this technology we have ever seen so far. And that's one part of the story, Maron, of course. But you say there that the patient started to recover really quite quickly after

His lungs were removed. Do we know why that happened? What was going on there? Absolutely. And you're right, this is only half of the story. I think all of the headlines say artificial lung system, which is amazing. But the other half of the story is that they analyzed his lungs after they were taken out of his body. And of course

It showed the presence of both influenza virus and this bacteria that I mentioned earlier. And it also showed pretty much irreversible damage to his lung tissue. So once he had entered that R's the acute respiratory distress syndrome stage. He wasn't going to be able to recover. Now, of course, this is only handy to know, sort of in theory, because obviously it already taken his lungs out of his body. But this is something that doctors have had lots of questions about for a long time.

once a patient enters ARDS, can they fully recover? Is it possible for us to just wait and put them on a ventilator or maybe even ECMO, this other earlier version of the technology that I mentioned, and just wait for them to recover? And this is a new piece of evidence in saying maybe once the patient reaches a certain stage of that

acute respiratory distress syndrome, they will not be able to recover and they will need a lung transplant. So this is new evidence that we haven't had before that that's the case. That's what's happening inside the lungs during arts. Well it's nice to start with the good news

story. Do we know anything about the patient themselves? Have they said anything about how they're doing, you know, what they think about the treatment they underwent? Well, other than the reports from his doctors that say he's doing well and his lungs are healthy, this man has chosen to remain anonymous as much as we'd all love to know his thoughts.

Well, if you are listening, very best of luck to you. Let's move on to our second story, and this is one that I read about in Nature based on on a nature study. And long-term listeners to the podcast will know that what I'm about to talk about is something that I have covered many times, namely how cancer cells evade the body's

defenses. Like I think last year I covered how cancer cells can palm off their dysfunctional mitochondria into immune cells to kind of power them down, right? So a variety of ways to get around it and this is another one of those. I mean cancer cells are sneaky. They've got all kinds of methods for getting past the body's defence systems. Absolutely. And in this case it seems to be that some tumors boost their own growth by commandeering a type of neuron called a sensory neuron. And

Essentially hijacking its function. Whoa. And so these neurons, they're not just in our brain, right? We've got sensory neurons all over our body. Absolutely right. There are a variety of different highways that reach out to different organs, different limbs. Now nerve cells are known to reside in tumors, but working out whether they have a role in the survival of said tumors has been difficult. Now there's a few reasons for this. One is in the past, genetic tools

haven't really been sophisticated enough to tease out a neuron's activity, right? Getting that signal from the noise. But also neurons as cells can be really, really, really long, right? And Generally the genetic material is kind of stored at one end at kind of the head, and they have this kind of long fibre like tendrils called dendrites.

And often it's these bits that plug into the tumour. So when someone takes a biopsy, they might get the tail and not have the genetic information from the head, as it were. But in this case the team have worked out a way to kind of get around that and inactivate specific sensory neurons. Now, they're looking at the vagus nerve. This is a really, really important

sensory signalling highway that goes between the brain and many parts of the body, as we've said there the heart, the lungs, the digestive system, all over the place, right? It's the biggie. Indeed. And this work, it has to be said, is done in mice, double underline mice. But

What they're looking at here is lungs and the nerves innervating lung tumours. And so what the team saw is when they inactivated neurons in this pathway, linking these lung tumor cells to the brain, what they thought would happen is This would switch off an important pathway telling the brain, hey, there's a tumor here, let's get your defense on. Right? They expected that.

to happen. But it was totally the opposite of that. When they inactivated the sensory neurons, they quote, saw such a huge dramatic reduction, end quote, in tumor growth. The tumor growth halved, like fifty percent reduction in growth. And this is where things take a turn. So what they think is happening is that ordinarily a signal is being sent up the vagus nerve to the brain in the mouse, but then another signal is being sent back to the tumour via a different neuronal pathway.

And what this return signal does is it releases a chemical called noradrenaline that ultimately suppresses tumor killing immune cells. So the cancer tricks the brain into turning off the its own immune system. So once again we have this very tricksy way that cancer cells can inhibit the immune system or in this case essentially just switch it off. Wow, that's really complex. And again, just one other way in their huge arsenal of tools that cancer cells are showing us, they have

Aaron Powell. And what's interesting here is that it shows that it seems there is a neuronal aspect, a brain aspect to this as well. It's been a lot of work about how cancer cells interact with nerves, but working out that there's this pathway that goes

all the way up and then all the way back down again. Is something that wasn't well understood and there had been some debate in the field about this kind of a situation. But of course, Maren, there are caveats to this. As I've said, this is a mouse model. This is one sort It's seen across the board, whether it's relevant in humans, is one of those things that we don't know

yet but we can choke this up on the board of things to think about when we're trying to work out how to attack cancer cells. Yes, and just another tick in the column of like look into this further because we could be able to use some of these mechanisms or target some of these mechanisms with potential future treatments. The mitochondrion thing that I talked about at the start, researchers are looking at that to try and work out is there ways that we can stop this happening. Of course these are

far, far down the track, but you have to start somewhere. You gotta start somewhere. Well two very interesting stories there. Marin, thank you so much for being here. Listeners, we will put links to both of those in the show notes and a link where you can sign up.

For the Nature Briefing to get even more stories delivered directly to your inbox. But for the time being, I've been Benjamin Thompson, Marin Huntsberger. Thank you so much for being here. Thanks so much for having me, and thank you, listeners, for having me in your ears. Thanks for listening, and we'll see you next time. Sedan vi början asset inom ekonomi och lön har vi fått högre kvalitet och tillgång till rätt kompetens.

Redovisning i vision och lön, för dig som tänker nytt. Mitt namn är Sigia Dropski. Olofå i kungen, det är ingen fucking greenscreen. Det här är den stora lögnen, en serie i fyra delar för podkasten mot tid. Den rikaste kriminella genom världhistorien, alla hans pengar kontrollerar vem om faktiskt sem man. En serie om hur nyt kunde bli Sanning, tills allt rasade. Missa inte. Motiv är en del av E-Kastfamiljen.